We describe the clinical course of a patient with extensive pulmonary tuberculosis, in whom fever persisted despite adequate anti-tuberculous and broad-spectrum antibiotic treatment. A once daily morning dose of prednisolone failed to suppress the fever, but a twice daily regime was successful.
Introduction
Despite the advent of extremely effective antituberculous drug regimes, fever may still persist for more than 2 weeks in many patients being treated for pulmonary tuberculosis (Kablawi et al., 1981) . We present such a patient in whom the fever was effectively suppressed by a twice-daily regime of prednisolone, but not by a single daily dose.
Case report
A 46-year-old single Irish museum attendant was admitted to hospital with a 3 month history of anorexia, severe weight loss, fever, night sweats and cough. On examination, he was pyrexial (38°C), cachectic and extremely weak, such that he could hardly stand up. The liver was palpable at 8 cm below the costal margin. There was no splenomegaly.
The chest X-ray ( Fig. 1 The course of the fever is shown on Fig. 2 . After a short period of abatement, the fever reappeared and tobramycin. However, it recurred 2 days before tobramycin and ampicillin were stopped. Blood cultures taken after cessation of these antibiotics remained negative. Prednisolone as a single morning dose of 40 mg was started with the aim of increasing the patient's well-being and appetite. The pattern of fever became distinctive, with a single daily spike of fever at around 6-7 am, during which the patient looked pale and unwell and experienced rigors and sweating. Further blood cultures taken during these episodes were negative. A course of gentamicin and ampicillin had no effect. Prednisolone was gradually reduced to a single daily morning dose of 10 mg. To test whether the fever was secondary to drug sensitivity, all anti-tuberculous drugs were stopped for 2 weeks, but this had no effect on the pattern of fever.
Finally, prednisolone, 10 mg given twice daily at 6 am and 6 pm, suppressed the fever. When one evening dose of prednisolone was deliberately omitted, the 6 am fever accompanied by rigors and sweating reappeared the following day. The patient's general condition had started to improve shortly after prednisolone was commenced. At the time of discharge from hospital, he had gained 2.5 kg in weight, the ESR was 20 mm/hr and plasma sodium and potassium concentrations were within normal range. He continued on prednisolone 10 mg twice daily at home, in combination with rifampicin and isoniazid and denied any recurrence of morning fevers and rigors at home. Prednisolone was discontinued 3 months after discharge from hospital.
Discussion
In a recent study (Kablawi et al., 1981) , 36% of a group of 59 febrile patients with pulmonary tuberculosis being treated with isoniazid and ethambutol plus either streptomycin or rifampicin had persistent fever for more than 2 weeks. Similar results were reported in an earlier study (Berger and Rosenbaum, 1968) where patients were treated with isoniazid and para-aminosalicyclic acid with or without streptomycin. Patients with clinically and radiologically faradvanced disease, as in this patient, were more likely to experience prolonged fever (Kablawi et al., 1981) .
The cause of the prolonged fever in this patient is unlikely to be due to a pulmonary or extrapulmonary bacterial infection as the fever did not respond to intensive antibiotic therapy. Febrile reactions with spiking fever and rigors have been described in patients treated with isoniazid alone or in combination with other anti-tuberculous drugs (Dasta, Prior and Kurzok, 1979; Berte, DiMase and Christianson, 1964) . However, discontinuation of all these drugs did not result in a reduction or disappearance of the fever. It is more likely that the prolonged fever was associated with the pulmonary tuberculosis itself, but the precise mechanism is unclear. Release of endogenous pyrogens from monocytes, which are activated by lymphokines released by specifically sensitized lymphocytes in cell-mediated immunity (Atkins, Francis and Bernheim, 1978) might be involved.
Corticosteroids were used in this patient in order to increase well-being and appetite (Horne, 1960 ) and a once-daily, morning dose of prednisolone was instituted so as to minimise pituitary-adrenal axis suppression (Nichols, Nugent and Tyler, 1965) . The use of corticosteroids as an antipyretic agent in pulmonary tuberculosis has not been previously reported, though it has been used in other bacterial infections, in conjunction with antibiotic therapy (Klastersky, 1971) . With a morning daily dose of prednisolone therapy, the pyrexia regularised and occurred at around 6 am daily, but was abolished when prednisolone was given twice-daily. The most likely explana-tion for these observations is that prednisolone given orally in normal subjects has a relatively short plasma half-life of 2 to 3.5 hr (Pickup, 1979) .
Rifampicin may further decrease it through liver enzyme induction (Edwards et al., 1974) . Thus, the plasma concentration of prednisolone after a single morning dose would have been virtually nil in the mornings, thus allowing the pyrexia to occur then.
After exclusion of concomitant bacterial infections and of drug sensitivity, prednisolone may be used to suppress the prolonged fever of patients treated for advanced pulmonary tuberculosis, but it should, at least, be given on a 12-hr daily basis. 
